ArticleOncology reports2018

Specific inhibitor of Notch‑3 enhances the sensitivity of NSCLC cells to gemcitabine.

Bi-Dan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.